Trials / Completed
CompletedNCT01375803
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity
Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Cargill · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study will critically evaluate the effects of a novel dietary fiber administered to subjects at high risk for developing diabetes to determine if this intervention will improve insulin sensitivity compared to control product administration and, thus, decrease risk for developing diabetes. The hypothesis is that consuming this novel fiber twice a day for 12 weeks will significantly decrease fasting plasma glucose, insulin and glycosylated hemoglobin values in pre-diabetic subjects (i.e. subjects with fasting plasma glucose levels 95-140 mg/dl at screening) compared to consumption of the control product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Novel dietary fiber | oral consumption in beverage |
| DIETARY_SUPPLEMENT | Novel dietary fiber | Oral consumption in beverage |
| OTHER | Placebo | Oral consumption in beverage |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2011-06-17
- Last updated
- 2011-06-17
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01375803. Inclusion in this directory is not an endorsement.